We are live on ! Find out more
UOC

UBS O'Connor Portfolio holdings

AUM $3.76B
1-Year Est. Return 62.41%
This Fund
S&P 500
This Quarter Est. Return
+0.05%
1 Year Est. Return
+62.41%
3 Year Est. Return
+179.84%
5 Year Est. Return
+371.69%
10 Year Est. Return
+1,534.25%
AUM
$3.55B
AUM Growth
+$59.4M
Cap. Flow
-$31.8M
Cap. Flow %
-0.9%
Top 10 Hldgs %
49.57%
Holding
665
New
156
Increased
155
Reduced
111
Closed
128
Avg Time Held Equity + Options
3.9 quarters
Top 10 Avg Time Held Equity + Options
0.8 quarters
Top 20 Avg Time Held Equity + Options
1.2 quarters
Avg Time Held Equity only
4.3 quarters
Top 10 Avg Time Held Equity only
0.8 quarters
Top 20 Avg Time Held Equity only
1.2 quarters

Sector Composition

Rank Sector Weight
1 Energy 26.53%
2 Technology 21.03%
3 Healthcare 14.68%
4 Industrials 8.19%
5 Miscellaneous 6.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
ITCI icon
476
PUT
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$14.6K ﹤0.01%
+15,000
New +$1.04M
2024 Q2
0 quarters
RENEW icon
477
DELISTED
Cartesian Growth Corporation II Warrant
RENEW
$13.7K ﹤0.01%
122,826
– –
2023 Q4
2 quarters
MAR icon
478
PUT
Marriott International
MAR
$95.1B
$13.6K ﹤0.01%
16,000
– –
2024 Q1
1 quarter
SBXC.WS icon
479
DELISTED
SilverBox Corp III Redeemable warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50
SBXC.WS
$13.2K ﹤0.01%
91,076
– –
2023 Q4
2 quarters
EXEL icon
480
CALL
Exelixis
EXEL
$15.1B
$13K ﹤0.01%
+40,000
New +$887K
2024 Q2
0 quarters
TPC icon
481
PUT
Tutor Perini Cor
TPC
$4.36B
$12.6K ﹤0.01%
90,000
-3,700
-4% -$68K
2024 Q1
1 quarter
VST icon
482
PUT
Vistra
VST
$54.5B
$12.6K ﹤0.01%
27,900
– –
2024 Q1
1 quarter
JTAIW icon
483
DELISTED
Jet.AI Inc. Warrant
JTAIW
$12.2K ﹤0.01%
197,427
– –
2022 Q3
7 quarters
BEAM icon
484
CALL
Beam Therapeutics
BEAM
$2.65B
$12K ﹤0.01%
+30,000
New +$737K
2024 Q2
0 quarters
MCAAW icon
485
DELISTED
Mountain & Co. I Acquisition Corp. Warrant
MCAAW
$11.9K ﹤0.01%
136,155
– –
2022 Q1
9 quarters
KDKRW icon
486
Kodiak AI Warrants
KDKRW
$11.4K ﹤0.01%
85,383
– –
2023 Q4
2 quarters
MIRM icon
487
CALL
Mirum Pharmaceuticals
MIRM
$5.48B
$11.3K ﹤0.01%
10,000
-15,000
-60% -$393K
2024 Q1
1 quarter
SEDA.WS icon
488
DELISTED
SDCL EDGE Acquisition Corporation Redeemable warrants, each whole warrant exercisable for one share of Class A ordinary share at an exercise price of $11.50
SEDA.WS
$10.8K ﹤0.01%
49,013
– –
2022 Q1
9 quarters
SPECW icon
489
DELISTED
Spectaire Holdings, Inc. Warrant
SPECW
$10.4K ﹤0.01%
231,101
– –
2022 Q1
9 quarters
AZN icon
490
CALL
AstraZeneca
AZN
$245B
$10.3K ﹤0.01%
+7,500
New +$1.13M
2024 Q2
0 quarters
USARW icon
491
DELISTED
USA Rare Earth Inc Warrant
USARW
$10.2K ﹤0.01%
103,486
– –
2023 Q4
2 quarters
CSLMW icon
492
DELISTED
CSLM Acquisition Corp. Warrant
CSLMW
$9.97K ﹤0.01%
68,781
– –
2023 Q1
5 quarters
M icon
493
CALL
Macy's
M
$5.84B
$9.75K ﹤0.01%
150,000
– –
2024 Q1
1 quarter
RAPT icon
494
CALL
DELISTED
RAPT Therapeutics
RAPT
$9.38K ﹤0.01%
3,125
– –
2024 Q1
1 quarter
FAASW icon
495
DELISTED
DigiAsia Corp Warrant
FAASW
$9.29K ﹤0.01%
138,661
– –
2023 Q1
5 quarters
TREE icon
496
PUT
LendingTree
TREE
$349M
$8.75K ﹤0.01%
50,000
– –
2024 Q1
1 quarter
IVCAW icon
497
DELISTED
Investcorp AI Acquisition Corp. Warrant
IVCAW
$8.21K ﹤0.01%
214,435
– –
2023 Q4
2 quarters
AENTW icon
498
Alliance Entertainment Holding Corp Warrants
AENTW
$1.53M
$8.18K ﹤0.01%
116,781
– –
2023 Q2
4 quarters
GILD icon
499
CALL
Gilead Sciences
GILD
$187B
$7.8K ﹤0.01%
+30,000
New +$2M
2024 Q2
0 quarters
PLAOW icon
500
DELISTED
Patria Latin American Opportunity Acquisition Corp. Warrant
PLAOW
$7.57K ﹤0.01%
178,033
– –
2023 Q4
2 quarters

Similar funds

UBS O'Connor's Q2 2024 Portfolio in Review

As of Q2 2024, UBS O'Connor held 665 positions worth $3.55B, up 1.7% from $3.49B the previous quarter. Its ten largest holdings account for 50% of the portfolio.

UBS O'Connor's Q2 2024 filing shows 156 new, 155 increased, 111 reduced and 128 closed positions. Its largest new stake was Endeavor Group Holdings, Inc.: 4,789,930 shares worth $129M. The largest sale was Pioneer Natural Resource Co., an estimated $638M.

By sector, the portfolio is most concentrated in Energy at 27% of assets, down from 34% a quarter earlier, followed by Technology and Healthcare.

  • UBS O'Connor's largest Q2 2024 buy was Endeavor Group Holdings, Inc.: 4,789,930 shares worth $129M.
  • UBS O'Connor added most to HashiCorp, Inc. Class A Common Stock in Q2 2024, an estimated $138M increase.
  • UBS O'Connor's biggest Q2 2024 reduction was Cerevel Therapeutics Holdings, Inc. Common Stock, cutting an estimated $51.2M.
  • UBS O'Connor fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $638M.
  • UBS O'Connor's ten largest holdings make up 50% of its $3.55B portfolio in Q2 2024.
  • UBS O'Connor opened 156 new positions and closed 128 in Q2 2024.
  • UBS O'Connor's portfolio value rose 1.7% quarter-over-quarter to $3.55B.

Based on UBS O'Connor's 13F filing for Q2 2024, filed 14 Aug 2024.